Hard to Treat Diseases Inc.
OTC: HTDS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Shimin Yuan
- Headquarters
- Shenzhen, China
- IPO year
- 1998
- Market cap
- $109.6K
- Website
- https://www.mellowhope.com
Loading HTDS…
Loading profile data…Frequently asked questions about HTDS
What does Hard to Treat Diseases Inc. (HTDS) do?
Hard to Treat Diseases Inc. (HTDS), founded in 2009 and headquartered in Shenzhen, China, is a pharmaceutical firm engaged in the development, manufacturing, and global export of biopharmaceutical products and vaccines. The company's extensive portfolio includes a range of biological agents such as reteplase (rPA), mycobacterium vaccae, acutobin...
Where does HTDS trade?
Hard to Treat Diseases Inc. (HTDS) trades on the Other OTC.
What sector is HTDS in?
Hard to Treat Diseases Inc. (HTDS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Hard to Treat Diseases Inc.?
Shimin Yuan is the chief executive officer of Hard to Treat Diseases Inc. (HTDS).
Where is Hard to Treat Diseases Inc. headquartered?
Hard to Treat Diseases Inc. is headquartered in China.
Does HTDS pay a dividend?
Hard to Treat Diseases Inc. (HTDS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HTDS go public?
Hard to Treat Diseases Inc. (HTDS) completed its initial public offering in 1998.